VivoSim Labs (VIVS) Common Equity (2011 - 2026)
VivoSim Labs (VIVS) reported Common Equity of -$2.35 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $9.54 million a year earlier.
Powered by 
Analysis
VivoSim Labs (VIVS) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), VivoSim Labs posted Common Equity of -$1.1 million.
- By fiscal year, Common Equity came in at $10.49 million in FY2025 (+191.4%), $3.6 million in FY2024 (-76.5%), $15.33 million in FY2023 (-49.3%) and $30.21 million in FY2022 (-22.9%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Common Equity in data going back to fiscal Q4 2011.
- Year over year, Common Equity gained in three of the last five quarters, with growth averaging 35.2%.
- The high point for year-over-year Common Equity in five years was fiscal Q4 2025 (growth of 191.4%); the low point was fiscal Q3 2025 (a decline of 94.1%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$1.1 million (Q4 2026), $4.44 million (Q3 2026) and $7.07 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.17 Bn | 35.87 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 17.45 Bn | 15.51 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Charles River Laboratories International | 14.37 Bn | 13.56 Bn | 363.37 Mn | 2.85 Bn |
| 4 | Icon | 13.16 Bn | 10.27 Bn | 479.29 Mn | 9.38 Bn |
| 5 | Fortrea Holdings | 2.12 Bn | 1.50 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Ginkgo Bioworks Holdings | 625.60 Mn | -136.48 Mn | 18.44 Mn | 420.28 Mn |
| 7 | Evotec SE | 506.10 Mn | -1.10 Bn | - | 760.23 Mn |
| 8 | Champions Oncology | 65.60 Mn | 40.68 Mn | 7.70 Mn | 4.46 Mn |
| 9 | MindWalk Holdings | 61.22 Mn | 24.88 Mn | 1.61 Mn | 4.93 Mn |
| 10 | VivoSim Labs | 832,550.47 | -16.89 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.35 Mn |
| Mar 31, 2026 | -1.10 Mn |
| Dec 31, 2025 | 4.44 Mn |
| Sep 30, 2025 | 7.07 Mn |
| Jun 30, 2025 | 9.54 Mn |
| Mar 31, 2025 | 10.49 Mn |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Sep 30, 2023 | 8.46 Mn |
| Jun 30, 2023 | 11.78 Mn |
| Mar 31, 2023 | 15.33 Mn |
| Dec 31, 2022 | 22.29 Mn |
| Sep 30, 2022 | 25.01 Mn |
| Jun 30, 2022 | 27.65 Mn |
| Mar 31, 2022 | 30.21 Mn |
| Dec 31, 2021 | 31.29 Mn |
| Sep 30, 2021 | 34.21 Mn |
API Access
VivoSim Labs Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VIVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VIVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VIVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();